Abbott Laboratories (ABT)

120.07
-3.20(-2.60%)
Pre Market
120.00
-0.07(-0.06%)
- Real-time Data
  • Volume:
    14,694,922
  • Bid/Ask:
    119.78/120.99
  • Day's Range:
    119.00 - 121.68

ABT Overview

Prev. Close
123.27
Day's Range
119-121.68
Revenue
43.08B
Open
119.19
52 wk Range
105.36-142.6
EPS
3.95
Volume
14,694,922
Market Cap
205.92B
Dividend (Yield)
1.88
(1.41%)
Average Volume (3m)
5,738,174
P/E Ratio
30.37
Beta
0.78
1-Year Change
4.65%
Shares Outstanding
1,714,968,237
Next Earnings Date
19 Apr 2022
What is your sentiment on Abbott Laboratories?
or
Market is currently closed. Voting is open during market hours.

Abbott Laboratories Company Profile

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellBuy
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Buy
SummarySellStrong SellStrong SellStrong SellStrong Buy
  • trump sign 750 million deal with Abbott will go up??
    1
    • 750M deal and the company is valued at 196B... use your brain
      1
    • Yeah! It will go up a lot! Like 2%!
      0
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.